Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
about
New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.The 100 most-cited articles on cardiovascular diseases from Mainland ChinaComparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention - A single centre observational study.Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial.Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization : A real world experience.The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis.One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials.Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisDeveloping drugs for use before, during and soon after percutaneous coronary intervention.Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST-segment elevation myocardial infarctions: Comparison of outcomes in a "real-world" setting.Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes.Anticoagulation in coronary intervention.Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.Antithrombotic Selection in ST-Segment Elevation Myocardial Infarction: a Year in Review.Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.Antithrombotic therapy for patients with STEMI undergoing primary PCI.Acute Coronary Stent Thrombosis in Modern Era: Etiology, Treatment, and Prognosis.Post-Procedural Bivalirudin Infusion Following Primary PCI to Reduce Stent Thrombosis.Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction.The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes.Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review.New "P" in Medical Model.BRIGHT HORIZONS for Bivalirudin? EUROMAXimizing benefits of bleeding risk but catching a MATRIX of HEAT for stent thrombosis.Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
P2860
Q26765488-7451B151-341F-4D47-8779-AB058AF09641Q33435616-8762D12A-0DAD-496B-A953-638D0BC8A659Q35641465-3D699CBF-B8D8-4021-B2F1-3CF32EA232B4Q35756591-BF2BDDBB-2ACC-4861-BCF4-526714E527A4Q36033582-E017A389-439F-41D5-8D5C-6F4DB4F8D448Q36251279-AEEEE444-A026-437F-B76E-03202134A009Q36322605-1823B589-18CA-4DEF-AAC1-CB129D72C0B1Q36362768-0FA09FE7-963A-46D2-899C-F03FFBBAE8BBQ37240704-3240B307-40A5-424D-AF78-AED7EDD20C50Q37329447-D2F36099-A6C9-4688-A757-E79697665118Q37444715-2BA853FB-E83A-424C-B6B2-FB743186A7C1Q37510674-A3745EDC-39AE-4BB0-B2CF-293CC5EB71D0Q37713084-4657D618-79A8-435D-849E-0EC6B1D684C3Q38379744-B29206AE-80FE-49CE-9EE4-CF118B76E55CQ38380117-6D558773-E3D2-41AF-A332-D7E4ECF2E66FQ38383037-42E44333-BFE6-40EF-B431-C58A358AD122Q38391491-9158C479-B4A0-466B-AD05-9901A2B0B4A6Q38423493-167909A0-85A6-4C4B-8415-003276150859Q38547727-4140C629-716A-48F8-9425-FA36281BD75BQ38661324-9B940CC1-4314-47D7-8080-1E04CB45ED17Q38708145-90C0717A-E6EE-4DD9-83A6-E3B481F61E20Q38736998-CFEBD1A2-16BC-407A-B42E-B4F0E59E8E78Q38760067-A211E21B-9735-4FC7-985B-02891D3D761CQ38762278-AF5A227C-EF39-4FD7-A275-EF05FA036F76Q38850355-36DDA636-135F-43D9-9CB6-728DD6886691Q38875031-359F7A47-BAD1-43D0-9DA6-27E080218276Q39022866-63E50B60-4884-4CFC-BB36-A0152036B460Q39147735-14BAA8DD-ABC7-4611-980B-D19D2236C630Q39284272-EAA72482-DDEC-4A21-BEA8-01CE38513EB7Q40046182-F8693B3B-DEAA-46AA-8A7C-2B2E93E2824FQ40191441-A5A6EF15-BEF5-4F6D-B154-3C95CC4F86CBQ40719468-CEEAAE82-7342-41F7-BE7B-BE54AE917496Q40783270-809C9B80-B948-4737-801A-F9DBC75B2FCCQ40980724-B000F436-40AF-4AFA-9FFF-71F1784B0C65Q41090807-559656F2-E214-4B76-BE2B-4F32A4255B41Q41365045-FCF65FD4-6BDB-4B6C-BF7E-9A6A7DC5C8F3Q42707980-2ED71B41-E8E6-4323-BC02-42E73B4CBEEDQ42943210-4A10E97E-E6B7-46D3-9360-3EBF9A42D75CQ43121978-225A4F2A-3F5D-4D4A-945E-F77D7E21FECAQ45047388-F7BD3AFD-82E6-4CDA-811D-E67BF872C5D6
P2860
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@ast
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@en
type
label
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@ast
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@en
prefLabel
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@ast
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@en
P2093
P356
P1476
Bivalirudin vs heparin with or ...... GHT randomized clinical trial.
@en
P2093
BRIGHT Investigators
Dongju Jiang
Gregg W Stone
Haiwei Liu
Hongyun Zang
Jincheng Guo
Jiyan Chen
P304
P356
10.1001/JAMA.2015.2323
P407
P577
2015-04-01T00:00:00Z